Evaluation of the Effects of Sequential Multiple-Dose Regimens of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia.
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2012
At a glance
- Drugs Cariprazine (Primary) ; Moxifloxacin; Risperidone
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- Sponsors Forest Laboratories
- 07 Feb 2012 Actual patient number (129) added as reported by ClinicalTrials.gov.
- 07 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Dec 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.